The 2023-24 epidemic of Oropouche fever in the Region of the Americas suggests a potential change in the epidemiology of the disease, raising questions about which vectors are driving transmission.
In a pre-print study published on October 18, 2024, researchers systematically reviewed vector competence experiments with the Oropouche virus (OROV) published before the 2023-24 epidemic season.
Only seven studies were published by September 2024, highlighting the chronic neglect that OROV has been subjected to since its discovery in 1954.
-
-
COVID-19 Pandemic Challenges Osteoporosis Management
-
AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials
-
Survival From COVID-19 High in Patients With Psoriasis
-
FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say
